Literature DB >> 28508173

Neuroprotective Effects of Lycium barbarum Polysaccharide on Focal Cerebral Ischemic Injury in Mice.

Peng Zhao1,2, Ru Zhou2, Xiao-Yun Zhu2, Gang Liu2, Yu-Ping Zhao2, Peng-Sheng Ma2, Wei Wu2, Yang Niu3, Tao Sun4, Yu-Xiang Li5, Jian-Qiang Yu6,7, Zhong-Ming Qian8,9.   

Abstract

Increasing evidence demonstrates inflammation contributes to neuronal death following cerebral ischemia. Lycium barbarum polysaccharide (LBP) has been reported to prevent scopolamine-induced cognitive and memory deficits. We recently indicated that LBP exerts neuroprotective effect against focal cerebral ischemic injury in mice via attenuating the mitochondrial apoptosis pathway. The aim of this study was to investigate the neuroprotective effects of LBP against the behavioral dysfunction induced by focal cerebral ischemia injury in mice. Following 7 successive days of pretreatment with LBP (10, 20 and 40 mg/kg) and nimodipine (4 mg/kg) by intragastric gavage, mice were subjected to middle cerebral artery occlusion (MCAO). Following reperfusion, cerebral blood flows, the total power of the spontaneous EEG, and morphological changes were estimated. Learning and memory ability, and motor coordination were determined by Morris water maze task, rotarod and grip test. Western blot analysis, Real-Time fluorogenic PCR assays, and immunofluorescence staining were used to examine the expression of proinflammatory mediators and activation of microglia. The present study showed that LBP pretreatment significantly enhanced regional cortical blood flow and the total power of the spontaneous EEG, improved memory and motor coordination impairments, and inhibited over-activation of microglia and astrocytes after MCAO. Further study demonstrated LBP suppressed MCAO-induced activations of P65 NF-κB and P38 MAPK, and prevented up-regulations of proinflammatory mediators in hippocampus. Our data suggest that LBP can exert functional recovery of memory and motor coordination deficits and neuroprotective effect against cerebral ischemic injury in mice.

Entities:  

Keywords:  Focal cerebral ischemia; Learning and memory deficits; Lycium barbarum polysaccharide; P38 MAPK; P65 NF-κB; Proinflammatory mediators

Mesh:

Substances:

Year:  2017        PMID: 28508173     DOI: 10.1007/s11064-017-2293-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

1.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

2.  Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia.

Authors:  D Stephenson; T Yin; E B Smalstig; M A Hsu; J Panetta; S Little; J Clemens
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

3.  Delayed inhibition of c-Jun N-terminal kinase worsens outcomes after focal cerebral ischemia.

Authors:  Yoshihiro Murata; Norio Fujiwara; Ji Hae Seo; Feng Yan; Xiangrong Liu; Yasukazu Terasaki; Yumin Luo; Ken Arai; Xunming Ji; Eng H Lo
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

4.  Protective effects of extract of Coeloglossum viride var. bracteatum on ischemia-induced neuronal death and cognitive impairment in rats.

Authors:  Bo Ma; Min Li; Hua Nong; Jiangong Shi; Gengtao Liu; Jianjun Zhang
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

5.  The usefulness of operant conditioning procedures to assess long-lasting deficits following transient focal ischemia in mice.

Authors:  André Ferrara; Sophie El Bejaoui; Sandrine Seyen; Ezio Tirelli; Jean-Christophe Plumier
Journal:  Behav Brain Res       Date:  2009-08-15       Impact factor: 3.332

Review 6.  Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

Authors:  Stephen W Scheff; Douglas A Price
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

7.  Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage.

Authors:  Meihua He; Hong Pan; Raymond Chuen-Chung Chang; Kwok-Fai So; Nicholas C Brecha; Mingliang Pu
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

8.  Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats.

Authors:  Weiwei Chen; Xiang Cheng; Jinzhong Chen; Xin Yi; Dekang Nie; Xiaohui Sun; Jianbing Qin; Meiling Tian; Guohua Jin; Xinhua Zhang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  Ultrasound-enhanced protective effect of tetramethylpyrazine against cerebral ischemia/reperfusion injury.

Authors:  Chunbing Zhang; Fengmeng Teng; Juan Tu; Dong Zhang
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

10.  Lycium barbarum polysaccharide prevents focal cerebral ischemic injury by inhibiting neuronal apoptosis in mice.

Authors:  Tengfei Wang; Yuxiang Li; Yongsheng Wang; Ru Zhou; Lin Ma; Yinju Hao; Shaoju Jin; Juan Du; Chengjun Zhao; Tao Sun; Jianqiang Yu
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more
  3 in total

1.  Oxymatrine Alleviates Hyperglycemic Cerebral Ischemia/Reperfusion Injury via Protecting Microvessel.

Authors:  Wen-Jun Wang; Yan-Mei Ma; Mao-Tao He; Deng-Hai Zhang; Rui Wang; Li Jing; Jian-Zhong Zhang
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

2.  Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study.

Authors:  Xiaoyue Li; Xuan Mo; Tao Liu; Robin Shao; Kayla Teopiz; Roger S McIntyre; Kwok-Fai So; Kangguang Lin
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

Review 3.  Mitochondrial MPTP: A Novel Target of Ethnomedicine for Stroke Treatment by Apoptosis Inhibition.

Authors:  Yangxin Li; Jiayi Sun; Ruixia Wu; Jinrong Bai; Ya Hou; Yong Zeng; Yi Zhang; Xiaobo Wang; Zhang Wang; Xianli Meng
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.